Search Orphan Drug Designations and Approvals
-
Generic Name: | mouse-human chimeric antibody of the IgG1 isotype, directed against human CD37 |
---|---|
Date Designated: | 03/24/2015 |
Orphan Designation: | Treatment of chronic lymphocytic leukemia (CLL). |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Boehringer Ingelheim Pharmaceuticals, Inc. 900 Ridgebury Rd., PO Box 368 Ridgefield, Connecticut 06877 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-